Scientists Have Discovered A Way To Make CRISPR Safer – Wall Street Pit
Wall Street Pit |
Scientists Have Discovered A Way To Make CRISPR Safer
Wall Street Pit CRISPR is currently being used to edit the genome of different organisms, and human clinical trials for various treatments are expected to begin. But something major is impeding the use of this very powerful gene-editing tool on humans, and that’s the … CRISPR goes wild, and scientists debate its fidelitySpectrum Atomic ‘photos’ help make gene editing saferEngadget Nicking in new nucleotidesEurekAlert (press release) |
|
Barrier proteins in tumors are possible key to immunotherapy success
Science Daily During the patient’s treatment, tumor surveillance with CT scans and clinical examinations had shown that some tumors were shrinking in response to immunotherapy, while others continued to grow. The patient’s history and the unusual access the … |
|
Stem Cell Transplant May Not Benefit Double-Hit Lymphoma Patients
Northwestern University NewsCenter Patients with double-hit lymphoma — a rare and aggressive variant of non-Hodgkin lymphoma — who achieved remission and underwent autologous stem cell transplantation did not remain in remission or live longer than patients who did not receive the … |
Genetic Literacy Project |
Redefining natural selection: How synthetic biology may solve sustainability challenges in food, fuel and health
Genetic Literacy Project [S]ynthetic biology] is poised to change how we feed ourselves, clothe ourselves, fuel ourselves—and possibly even change our very selves. While scientists have for decades been able to practice basic genetic engineering—knocking out a gene or moving … |
|
Celsion Announces Completion of OVATION Study and Provides Update on its Immunotherapy Trial in Advanced …
Nasdaq LAWRENCEVILLE, N.J., July 05, 2017 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ:CLSN) today provided an update on its Phase Ib dose escalating clinical trial (the OVATION Study) combining GEN-1, the Company’s IL-12 gene-mediated … |
|
New Frontier in Cancer Care: Turning blood into living drugs
Brattleboro Reformer As CAR–T cells swarm the cancer, an immune overreaction called “cytokine release syndrome” can trigger high fevers and plummeting blood pressure and in severe cases organ damage. Some patients also experience confusion, hallucinations or other … |
|
New Frontier in Cancer Care: Turning blood into living drugs | The …
The Manchester Journal SEATTLE — Ken Shefveland’s body was swollen with cancer, treatment after treatment failing until doctors gambled on a radical approach: They removed some … |